EpiCept
epicept.com
Tarrytown, United States · Founded 1999 · $2.0M raised
- Headquarters
- Tarrytown
- Employees
- 11–50
- Founded
- 1999
- Business Model
- B2B
- Website
- epicept.com
- Total Funding
- $2.0M
- Last Round
- $2.0M Series AFeb 2012
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
About
EpiCept Corporation was a specialty pharmaceutical company focused on the clinical development and commercialization of pharmaceutical products for the treatment of cancer and pain. The company's pipeline included Ceplene (histamine dihydrochloride), approved in the European Union in 2008 for treatment of acute myeloid leukemia, and Azixa, an oncology candidate. EpiCept merged with Immune Pharmaceuticals in 2013 and subsequently ceased independent operations. Headquartered in Tarrytown, New York.
Summary
EpiCept is a Biotech company based in Tarrytown, United States, founded in 1999. It has raised $2.0M in total across 1 round, most recently a $2.0M Series A round in Feb 2012.
Funding History
Feb 2012
Similar Companies
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
Global contract research organization providing comprehensive drug development and laboratory ser...
Specialty pharmaceutical company
Altos Labs combines academic science and industry development to create medicines that restore ce...
Appears in
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/epicept"><img src="https://indexed.vc/api/badge/company/epicept" alt="EpiCept on Indexed.vc" width="260" height="76" /></a>